Vepugratinib is an investigational new drug that is being evaluated by Loxo Oncology for the treatment of genitourinary cancer. It is a fibroblast growth factor receptor 3 antagonist.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.